These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34752937)

  • 41. Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument.
    Yost KJ; Sorensen MV; Hahn EA; Glendenning GA; Gnanasakthy A; Cella D
    Value Health; 2005; 8(2):117-27. PubMed ID: 15804320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issues.
    Wang Y; Ghadimi M; Wang Q; Hou L; Zeraatkar D; Iqbal A; Ho C; Yao L; Hu M; Ye Z; Couban R; Armijo-Olivo S; Bassler D; Briel M; Gluud LL; Glasziou P; Jackson R; Keitz SA; Letelier LM; Ravaud P; Schulz KF; Siemieniuk RAC; Brignardello-Petersen R; Guyatt GH
    J Clin Epidemiol; 2022 Dec; 152():218-225. PubMed ID: 36424692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minimum important difference for validated instruments in women with urge incontinence.
    Dyer KY; Xu Y; Brubaker L; Nygaard I; Markland A; Rahn D; Chai TC; Stoddard A; Lukacz E;
    Neurourol Urodyn; 2011 Sep; 30(7):1319-24. PubMed ID: 21563210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A narrative review and content analysis of functional and quality of life measures used to evaluate the outcome after TSA: an ICF linking application.
    Lu Z; MacDermid JC; Rosenbaum P
    BMC Musculoskelet Disord; 2020 Apr; 21(1):228. PubMed ID: 32284065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimal important differences of the SRS-22 Patient Questionnaire following surgical treatment of idiopathic scoliosis.
    Bagó J; Pérez-Grueso FJ; Les E; Hernández P; Pellisé F
    Eur Spine J; 2009 Dec; 18(12):1898-904. PubMed ID: 19533179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience.
    Yost KJ; Eton DT
    Eval Health Prof; 2005 Jun; 28(2):172-91. PubMed ID: 15851772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Minimal important difference to infer changes in health-related quality of life-a systematic review.
    Jayadevappa R; Cook R; Chhatre S
    J Clin Epidemiol; 2017 Sep; 89():188-198. PubMed ID: 28676426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer.
    Pickard AS; Neary MP; Cella D
    Health Qual Life Outcomes; 2007 Dec; 5():70. PubMed ID: 18154669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What Makes Suture Anchor Use Safe in Hip Arthroscopy? A Systematic Review of Techniques and Safety Profile.
    Shah A; Kay J; Memon M; Coughlin RP; Simunovic N; Nho SJ; Ayeni OR
    Arthroscopy; 2019 Apr; 35(4):1280-1293.e1. PubMed ID: 30878332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A point of minimal important difference (MID): a critique of terminology and methods.
    King MT
    Expert Rev Pharmacoecon Outcomes Res; 2011 Apr; 11(2):171-84. PubMed ID: 21476819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determining Thresholds for Meaningful Change for the Headache Impact Test (HIT-6) Total and Item-Specific Scores in Chronic Migraine.
    Houts CR; Wirth RJ; McGinley JS; Cady R; Lipton RB
    Headache; 2020 Oct; 60(9):2003-2013. PubMed ID: 32862469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishing clinical meaning and defining important differences for Patient-Reported Outcomes Measurement Information System (PROMIS
    Morgan EM; Mara CA; Huang B; Barnett K; Carle AC; Farrell JE; Cook KF
    Qual Life Res; 2017 Mar; 26(3):565-586. PubMed ID: 27913986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Psychometric characteristics of questionnaires designed to assess the knowledge, perceptions and practices of health care professionals with regards to alcoholic patients].
    Jaussent S; Labarère J; Boyer JP; François P
    Encephale; 2004; 30(5):437-46. PubMed ID: 15627048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form.
    Skolarus TA; Dunn RL; Sanda MG; Chang P; Greenfield TK; Litwin MS; Wei JT;
    Urology; 2015 Jan; 85(1):101-5. PubMed ID: 25530370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review.
    Cook JA; Hislop J; Adewuyi TE; Harrild K; Altman DG; Ramsay CR; Fraser C; Buckley B; Fayers P; Harvey I; Briggs AH; Norrie JD; Fergusson D; Ford I; Vale LD
    Health Technol Assess; 2014 May; 18(28):v-vi, 1-175. PubMed ID: 24806703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials.
    Gamper EM; Musoro JZ; Coens C; Stelmes JJ; Falato C; Groenvold M; Velikova G; Cocks K; Flechtner HH; King MT; Bottomley A;
    BMC Cancer; 2021 Oct; 21(1):1083. PubMed ID: 34620124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of Appearance: Definition of Appearance-Pain (App-Pain) and Systematic Review of Patient-Reported Outcome Measures Used in Literature.
    Barone M; Cogliandro A; Salzillo R; Tambone V; Persichetti P
    Aesthetic Plast Surg; 2018 Oct; 42(5):1399-1409. PubMed ID: 29922843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.